Cargando…
Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta‐analysis
Some randomized controlled trials have compared the effectiveness and safety outcomes between early initiation of Sacubitril/Valsartan and angiotensin‐converting enzyme inhibitors (ACEIs) in patients after acute myocardial infarction. Therefore, our current meta‐analysis aimed to clarify the confusi...
Autores principales: | Zhao, Jing, Zeng, Yuanyuan, Shen, Xiaoxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495087/ https://www.ncbi.nlm.nih.gov/pubmed/34464468 http://dx.doi.org/10.1002/clc.23717 |
Ejemplares similares
-
Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
por: Yang, Pei, et al.
Publicado: (2022) -
Protective effect of sacubitril/valsartan in patients with acute myocardial infarction: A meta-analysis
por: Liu, Shanshan, et al.
Publicado: (2022) -
The benefits of sacubitril–valsartan in patients with acute myocardial infarction: a systematic review and meta‐analysis
por: Xiong, Bo, et al.
Publicado: (2021) -
Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis
por: Liu, Lang, et al.
Publicado: (2022) -
Does sacubitril/valsartan work in acute myocardial infarction? The PARADISE-AMI study
por: Gatto, Laura
Publicado: (2021)